may
public
library
science
government
accountability
project
public
interest
legal
group
advises
support
whistleblower
private
meeting
near
capitol
building
washington
room
four
high
profile
medical
whistleblower
recent
time
four
gone
public
information
practice
medicine
medical
research
believe
risking
public
health
safety
one
david
graham
associate
director
united
state
food
drug
administration
fda
office
drug
safety
whose
research
rofecoxib
vioxx
pointed
serious
cardiovascular
risk
drug
graham
speaking
capacity
representing
fda
anonymous
fifth
research
scientist
major
drug
phone
whistleblower
took
turn
share
story
including
account
retaliation
said
faced
employer
raising
concern
led
lawsuit
least
two
whistleblower
picture
emerged
picture
american
medicine
inappropriate
tie
pharmaceutical
deeply
troubling
investigative
medical
journalist
jeanne
lenzer
report
essay
plo
medicine
whistleblower
spoke
public
regulatory
agency
putting
interest
drug
company
ahead
safety
patient
pharmaceutical
company
allow
marketing
department
knowingly
downplay
serious
side
effect
promoting
drug
spoke
woefully
inadequate
protection
offered
medical
community
feel
morally
compelled
blow
whistle
lenzer
conceived
idea
meeting
believed
important
lesson
would
emerge
medical
whistleblower
come
different
professional
background
together
one
room
share
experience
took
many
month
planning
particular
needed
gain
trust
industry
research
scientist
scientist
could
feel
sure
anonymity
would
preserved
planning
nearly
came
nothing
last
moment
original
journal
sponsor
pulled
advice
lawyer
picture
emerged
account
deeply
troubling
lenzer
phone
call
plo
enquiring
whether
might
step
came
ten
day
event
due
happen
took
legal
advice
agreed
sponsor
roundtable
plo
eager
support
event
willing
accept
small
legal
risk
believe
issue
raised
huge
interest
medical
community
press
patient
broader
public
event
fit
well
public
service
mission
making
scientific
medical
research
result
freely
publicly
available
belief
transparency
conduct
publication
research
important
public
trust
topic
roundtable
line
article
published
highlighting
many
way
medicine
become
tightly
entangled
industry
great
detriment
patient
risk
journal
sponsoring
event
course
much
smaller
risk
whistleblower
roundtable
faced
going
public
story
study
shown
whistleblower
public
service
private
industry
almost
always
experience
retaliation
employer
employed
longer
experiencing
greater
retaliation
risk
loss
earnings
intimidation
harassment
victimization
personal
abuse
traditionally
receive
little
help
statutory
authority
washington
whistleblower
story
illustrate
issue
psychiatrist
stefan
kruszewski
described
fired
job
pennsylvania
department
public
welfare
dpw
alerting
senior
prescribing
practice
across
state
considered
alarming
dangerous
fired
demeaning
manner
said
kruszewski
sued
dpw
firing
two
office
emptied
content
office
put
gutter
david
testified
senate
finance
committee
hearing
rofexocib
vioxx
fda
merck
conspiracy
senior
management
fda
intimidate
ahead
senate
testimony
individual
contend
pharmaceutical
industry
influence
employer
state
federal
regulatory
agency
respectively
played
part
difficulty
individual
faced
getting
concern
heard
lenzer
report
hope
spark
discussion
debate
american
researcher
regulatory
agency
medical
disentangle
influence
pharmaceutical
industry
past
medical
journal
editor
played
important
part
exposing
complex
relationship
pharmaceutical
industry
medicine
including
industry
medical
journal
plo
medicine
continue
look
critically
relationship
common
theme
roundtable
armed
information
public
could
important
role
unpicking
tie
complex
dismantled
said
graham
american
people
insist
otherwise
going
disaster
like
vioxx
happen
future
patient
health
professional
even
industry
surely
stand
gain
disentanglement